Pregnancy and reproductive risk factors for cardiovascular disease in women

AC O'Kelly, ED Michos, CL Shufelt, JV Vermunt… - Circulation …, 2022 - Am Heart Assoc
Beyond conventional risk factors for cardiovascular disease, women face an additional
burden of sex-specific risk factors. Key stages of a woman's reproductive history may …

[HTML][HTML] Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention

O Osibogun, O Ogunmoroti, ED Michos - Trends in cardiovascular …, 2020 - Elsevier
Although polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders
affecting women, its etiology is not entirely understood. Clinical symptoms of PCOS include …

Polycystic ovary syndrome

R Azziz, E Carmina, ZJ Chen, A Dunaif… - Nature reviews Disease …, 2016 - nature.com
Polycystic ovary syndrome (PCOS) affects 5–20% of women of reproductive age worldwide.
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …

Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome

DA Dumesic, SE Oberfield, E Stener-Victorin… - Endocrine …, 2015 - academic.oup.com
Polycystic ovary syndrome (PCOS) is a heterogeneous and complex disorder that has both
adverse reproductive and metabolic implications for affected women. However, there is …

Sex-and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature

G Pucci, R Alcidi, L Tap, F Battista… - Pharmacological …, 2017 - Elsevier
Metabolic syndrome (MS), a cluster of metabolic abnormalities linked to insulin-resistance
and abdominal obesity, is associated with an increased risk of Type II diabetes mellitus (DM) …

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline

RS Legro, SA Arslanian, DA Ehrmann… - The Journal of …, 2013 - academic.oup.com
Objective: The aim was to formulate practice guidelines for the diagnosis and treatment of
polycystic ovary syndrome (PCOS). Participants: An Endocrine Society-appointed Task …

Epidemiology, diagnosis, and management of polycystic ovary syndrome

SM Sirmans, KA Pate - Clinical epidemiology, 2013 - Taylor & Francis
Polycystic ovary syndrome (PCOS) is a common heterogeneous endocrine disorder
characterized by irregular menses, hyperandrogenism, and polycystic ovaries. The …

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

G Conway, D Dewailly… - European journal of …, 2014 - academic.oup.com
Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with
androgen excess in women, which justifies the growing interest of endocrinologists. Great …

[HTML][HTML] Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop …

BCJM Fauser, BC Tarlatzis, RW Rebar, RS Legro… - Fertility and sterility, 2012 - Elsevier
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in females, with
a high prevalence. The etiology of this heterogeneous condition remains obscure, and its …

American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of …

PS Jellinger, Y Handelsman, PD Rosenblit… - Endocrine Practice, 2017 - Elsevier
Objective The development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology …